Vitamin B12 deficiency.

U.S. Army Health Clinic, Darmstadt, Germany.
American family physician (Impact Factor: 1.82). 04/2003; 67(5):979-86.
Source: PubMed

ABSTRACT Vitamin B12 (cobalamin) deficiency is a common cause of macrocytic anemia and has been implicated in a spectrum of neuropsychiatric disorders. The role of B12 deficiency in hyperhomocysteinemia and the promotion of atherosclerosis is only now being explored. Diagnosis of vitamin B12 deficiency is typically based on measurement of serum vitamin B12 levels; however, about 50 percent of patients with subclinical disease have normal B12 levels. A more sensitive method of screening for vitamin B12 deficiency is measurement of serum methylmalonic acid and homocysteine levels, which are increased early in vitamin B12 deficiency. Use of the Schilling test for detection of pernicious anemia has been supplanted for the most part by serologic testing for parietal cell and intrinsic factor antibodies. Contrary to prevailing medical practice, studies show that supplementation with oral vitamin B12 is a safe and effective treatment for the B12 deficiency state. Even when intrinsic factor is not present to aid in the absorption of vitamin B12 (pernicious anemia) or in other diseases that affect the usual absorption sites in the terminal ileum, oral therapy remains effective.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin B12, also known as cobalamin, is a water-soluble vitamin that is important in the hematological and nervous systems, and it has a complex relationship with the skin. Altered cobalamin levels can lead to dermatological manifestations, which may indicate a deficiency or excess of this vitamin. The biochemistry and metabolism of cobalamin is complex, and diseases can be associated with alterations of this metabolic pathway. The cutaneous manifestations of cobalamin deficiency include hyperpigmentation (most commonly); hair and nail changes; and oral changes, including glossitis. Additionally, several dermatologic conditions, including vitiligo, aphthous stomatitis, atopic dermatitis, and acne are related to cobalamin excess or deficiency. The cutaneous complications of cobalamin therapy include acne, rosacea, and allergic site reactions, or anaphylaxis with cobalamin injections. As cobalt is a component of cobalamin, patients with cobalt sensitivity have been reported to have cutaneous manifestations when receiving cobalamin replacement therapy.
    American Journal of Clinical Dermatology 01/2015; 16(1). DOI:10.1007/s40257-014-0107-3 · 2.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: DBS assay offer sufficient sensitivity to measure MMA and tHCYS concentrations.•DBS matrix is superior for tHCYS stability.•Paired plasma and DBS samples were compared.•DBS samples for measurement of tHCYS is a good alternative approach for plasma.•For MMA, no correlation between DBS and plasma exist in the lower ranges.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Multiple sclerosis (MS) is an inflammatory, demyelinating disease that has unpredictable symptomatology and severity. Cerebellar manifestations in MS can be present at any time of the clinical course. Early cerebellar findings are a predictor of disability and disease progression. Most patients have cerebellar manifestations once they enter the progressive stages of the disease. Of the cerebellar findings, tremor is by far the most common. Copyright © 2014 Elsevier Inc. All rights reserved.
    Neurologic Clinics 10/2014; 32(4). DOI:10.1016/j.ncl.2014.08.001 · 1.61 Impact Factor


Available from
May 20, 2014